Amniotic MSCs reduce pulmonary fibrosis by hampering lung B‐cell recruitment, retention, and maturation

Amniotic MSCs reduce pulmonary fibrosis by hampering lung B‐cell recruitment, retention, and maturation

Abstract Growing evidence suggests a mechanistic link between inflammation and the development and progression of fibrotic processes. Mesenchymal stromal cells derived from the human amniotic membrane (hAMSCs), which display marked immunomodulatory properties, have been shown to reduce bleomycin‐ind...

Full description

Bibliographic Details
Main Authors: Anna Cargnoni, Pietro Romele, Patrizia Bonassi Signoroni, Serafina Farigu, Marta Magatti, Elsa Vertua, Ivan Toschi, Valentina Cesari, Antonietta R. Silini, Francesca R. Stefani, Ornella Parolini
Format: Article
Language:English
Published: Wiley 2020-09-01
Series:Stem Cells Translational Medicine
Subjects:
amniotic mesenchymal stromal cells
B lymphocytes
bleomycin
lung fibrosis
Online Access:https://doi.org/10.1002/sctm.20-0068

Internet

https://doi.org/10.1002/sctm.20-0068

Similar Items